HCW BiologicsHCWB
13F holders, Q1 2026 (March 31)15holders +1
5new positions
5sold out
1famous investor
$0.36avg. 13F price*
At the end of Q1 2026, 15 institutions reported holding HCW Biologics Inc. (HCWB) in their 13F filings, up 1 from Q4 2025. 5 opened new positions and 5 sold out. The largest holders were HRT Financial LP ($95K), Virtu Financial LLC ($17K) and Geode Capital Management, LLC ($13K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- HCW Biologics Inc.
- CUSIP
- 40423R204
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $117K |
| Exits | 5 | $357K |
All 13F filers, Q4 2025 → Q1 2026: 382,457 shares bought and 368,043 shares sold, net +14,414 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| HRT Financial LP | 0.00% | New | 266,393 | $95K |
| Virtu Financial LLC | 0.00% | New | 47,809 | $17K |
| Geode Capital Management, LLC | 0.00% | Add +155.7% | 35,886 | $13K |
| Citadel Advisors | 0.00% | Add +17.7% | 26,083 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +229.5% | 14,839 | $5K |
| Jane Street Group, LLC | 0.00% | New | 14,134 | $5K |
| Vanguard Capital Management LLC | 0.00% | — | 12,023 | $4K |
| Citigroup Inc. | 0.00% | Add +1052700.0% | 10,528 | $4K |
| Golden State Wealth Management, LLC | 0.00% | No change | 10,000 | $4K |
| UBS Group AG | 0.00% | Add +430.3% | 9,221 | $3K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 1,903 | $685 |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $360 |
| Osaic Holdings, Inc. | 0.00% | No change | 26 | $9 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 2 | $1 |
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is HCWB's weight in each manager's 13F, not the share of HCW Biologics Inc. the manager owns.